Page 18 - Risk Management Bulletin February 2024
P. 18

RMAI BULLETIN FEBRUARY 2024


             in the number of kids born with severe birth abnor-  Y  Limited understanding of foetal development: At
             malities, such as missing or deformed limbs, facial  the time, there was little understanding of how
             deformities, and other critical disorders, in the early  medications could affect foetal development. The
             1960s.It was soon established that thalidomide, which  safety testing on thalidomide was done on ani-
             had been taken by many pregnant women in the early  mals, which did not correctly reflect the possible
             stages of pregnancy, was the cause of severe birth  risks to human foetuses.
             abnormalities.
                                                              Y  Poor communication between regulators and
                                                                 healthcare providers: There was a dearth of com-
             The thalidomide disaster was linked back to poor drug  munication regarding the possible risks of thalido-
             testing and regulation. The medicine was licensed in
                                                                 mide among regulatory agencies and healthcare
             various countries, including Germany, without proper  professionals, allowing the medicine to be widely
             safety testing. In other countries, such as the United  prescribed without adequate knowledge of its ef-
             Kingdom, the medicine was approved based on animal
                                                                 fects.
             safety data that did not adequately reflect the hazards
             to human foetuses.
                                                              Lessons:
                                                              Y  The need of rigorous safety testing of drugs be-
             The thalidomide disaster had a significant impact on
                                                                 fore they are allowed for usage was underlined by
             the pharmaceutical business, as well as how pharma-
                                                                 the thalidomide disaster. New regulations were
             ceuticals are tested and regulated. Governments all
             throughout the world tightened medication approval  enacted to demand more extensive drug testing,
                                                                 particularly in sensitive populations such as preg-
             standards, requiring more stringent safety testing be-
                                                                 nant women and fetuses.
             fore new drugs could be marketed to the public. The
             significance of testing medications on pregnant women  Y  Better communication: The incident also high-
             and their foetuses before  to approval was also     lighted the significance of clear communication
             recognised, and new laws were enacted to ensure that  about the potential hazards and benefits of drugs
             this occurred.                                      among regulators, healthcare practitioners, and
                                                                 patients. Clearer communication could aid in the
             Thalidomide survivors and their families continue to  prevention of future disasters and ensuring that
             campaign for government and pharmaceutical sector   patients are aware of the potential risks of any
             support and help. Many of the affected children re-  medications supplied to them.
             quire specialised medical treatment as well as aid with  Y  Patient safety should be prioritized: The thalido-
             daily activities, and a number of organisations have  mide disaster served as a reminder of the signifi-
             been formed to provide support and advocacy for tha-  cance of putting patient safety first in drug devel-
             lidomide survivors. In addition, novel treatments, such  opment and regulation. Patient safety should be
             as prosthetic limbs and other assistive equipment,  the number one priority. Patient safety should be
             were created to help control the symptoms of thali-  the first priority in all aspects of healthcare, includ-
             domide-related illnesses.                           ing drug development, testing, and approval.

             Overall, the thalidomide disaster serves as a sharp Remedies:
             reminder of the need of testing for safety and efficacy  Y  Following the thalidomide disaster, drug testing
             in the development of new pharmaceuticals, as well  and approval requirements were dramatically
             as protecting vulnerable people from harm.          strengthened to require more extensive safety
                                                                 testing, particularly in sensitive groups such as
             Causes:                                             pregnant women and foetuses.
             Y   Thalidomide was approved in various countries  Y  Support for afflicted patients: Several organiza-
                 without proper safety testing, allowing the drug to  tions have been founded to provide thalidomide
                 be marketed to pregnant women without knowl-    survivors with support and advocacy, including
                 edge of the drug's potential hazards to foetuses.  medical care and assistance with daily activities.


                                                           16
   13   14   15   16   17   18   19   20   21   22   23